Skip to main content
ABSTRACT & COMMENTARY

Another Agent for Hypercholesterolemia

A pooled analysis of three trials of inclisiran in patients with atherosclerotic cardiovascular disease or its risk equivalent showed impressive reductions in LDL cholesterol with subcutaneous injections.